Novikoff Hepatoma Cells

Novikoff-Hepatoma, also known as Novikoff Hepatoma or NK, is a rat hepatocellular carcinoma cell line derived from a male Sprague Dawley rat (Rattus norvegicus). The tumor originated as an experimentally induced hepatoma and has been widely used as a transplantable and in vitro model of rat liver cancer. It represents a poorly differentiated hepatocellular carcinoma and is characterized by rapid proliferation and high tumorigenic capacity in syngeneic hosts. The N1-S1 cell line originates from the same individual tumor, indicating a shared genetic background between these related derivatives.

Novikoff-Hepatoma cells exhibit morphological and biochemical features consistent with malignant hepatocytes, including altered metabolic activity, dysregulated cell cycle control, and enhanced nucleolar and ribosomal biogenesis typical of rapidly growing hepatic tumors. Historically, this model has been extensively used in studies of liver carcinogenesis, tumor metabolism, RNA and protein synthesis, and chemotherapeutic response in rodent systems. Due to its robust growth characteristics and reproducibility, the line has served as a classical model in experimental oncology, particularly for investigating hepatocellular carcinoma biology in immunocompetent rat models.

As a Sprague Dawley – derived tumor line, Novikoff-Hepatoma is compatible with syngeneic transplantation studies in the corresponding rat strain, enabling investigation of tumor-host interactions, therapeutic interventions, and loco-regional treatment strategies such as intra-arterial drug delivery. Its well-documented experimental history and stable malignant phenotype make it a valuable preclinical model for mechanistic studies of hepatocellular carcinoma progression and treatment response in vivo and in vitro.